Research Projects

Neurotype Inc. is supported by grants from these federal and state agencies:

NIH SBIR Phase II Award (NeuromarkR™): EEG-based clinical decision support for opioid use disorder

NIH SBIR Phase II Award (NeuromarkR™): EEG-based clinical decision support for opioid use disorder

NIH SBIR Phase I Award: Closed-loop attention bias modification brain training for opioid use disorder

NIH SBIR Phase I Award: Closed-loop attention bias modification brain training for opioid use disorder

Honorable Mention: Product Prototypes to Combat Drug Craving Challenge

Honorable Mention: Product Prototypes to Combat Drug Craving Challenge

Innovation Grants: LaunchMN Innovation Grants

Innovation Grants: LaunchMN Innovation Grants

NIH SBIR Phase I Award: Mobile brain sensing platform for detection of opioid craving and treatment response

NIH SBIR Phase I Award: Mobile brain sensing platform for detection of opioid craving and treatment response

NIDA "$100,000 Start a SUD Startup" Challenge

NIDA "$100,000 Start a SUD Startup" Challenge

MNSBIR Catalyst Program

MNSBIR Catalyst Program

Innovation to Impact at Yale

Innovation to Impact at Yale

Updates & Press

Latest news, announcements, and press releases from Neurotype.

View Updates & Press
Address

Neurotype Inc.

Minnesota, USA

Email

info@neurotype.io

Social
  • PitchBook
NeuromarkR™ and Modit™ are investigational technologies under research and development.
© 2026 Neurotype Inc. All rights reserved. Third party logos and trademarks are the property of their respective owners.